June 4, 2017 In an analysis of 6 clinical trials with over 12,800 patients, 3 months of chemotherapy was nearly as effective as a standard 6-month course – with a difference in disease-free survival (DFS) of less than 1% – while reducing the risk of neurotoxicity and other adverse events. A subgroup analysis further showed...
Pro zobrazení tohoto obsahu je třeba být přihlášen.